A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Public ClinicalTrials.gov record NCT01321346. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Study identification
- NCT ID
- NCT01321346
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Therapeutic Advances in Childhood Leukemia Consortium
- Other
- Enrollment
- 30 participants
Conditions and interventions
Conditions
Interventions
- Cytarabine Drug
- Panobinostat Drug
Drug
Eligibility (public fields only)
- Age range
- 8 Years to 21 Years
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2011
- Primary completion
- Sep 30, 2015
- Completion
- Not listed
- Last update posted
- Nov 23, 2015
Started 2011
United States locations
- U.S. sites
- 20
- U.S. states
- 16
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Childrens Hospital Los Angeles | Los Angeles | California | 90027 | — |
| UCSF School of Medicine | San Francisco | California | 94143-0106 | — |
| Children's National Medical Center | Washington D.C. | District of Columbia | — | — |
| University of Miami Cancer Center | Miami | Florida | 33136 | — |
| Children's Healthcare of Atlanta, Emory University | Atlanta | Georgia | — | — |
| Lurie Children's Hospital | Chicago | Illinois | — | — |
| Dana Farber | Boston | Massachusetts | — | — |
| C.S. Mott Children's Hospital | Ann Arbor | Michigan | 48109-0914 | — |
| Childrens Hospital & Clinics of Minnesota | Minneapolis | Minnesota | 55404-4597 | — |
| New York University Medical Center | New York | New York | 10016 | — |
| Children's Hospital New York-Presbyterian | New York | New York | 10032 | — |
| Levine Children's Hospital at Carolinas Medical Center | Charlotte | North Carolina | 28203 | — |
| Rainbow Babies | Cleveland | Ohio | — | — |
| Nationwide Childrens Hospital | Columbus | Ohio | — | — |
| Oregon Health and Science University | Portland | Oregon | — | — |
| St. Jude | Memphis | Tennessee | 38105-3678 | — |
| Vanderbilt Children's Hospital | Nashville | Tennessee | — | — |
| Primary Children's | Salt Lake City | Utah | — | — |
| Seattle Children's Hospital | Seattle | Washington | 98105 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01321346, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 23, 2015 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01321346 live on ClinicalTrials.gov.